Medartis Holding AG
MDRSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.56 | -12.66 | 0.60 | -0.11 |
| FCF Yield | 2.57% | 0.14% | -3.52% | 1.66% |
| EV / EBITDA | 26.46 | 35.11 | 41.67 | 22.66 |
| Quality | ||||
| ROIC | 2.67% | 1.01% | -0.51% | 3.39% |
| Gross Margin | 79.47% | 79.04% | 74.05% | 76.04% |
| Cash Conversion Ratio | 9.09 | 32.28 | 0.68 | 3.06 |
| Growth | ||||
| Revenue 3-Year CAGR | 7.14% | 9.86% | 12.72% | 7.10% |
| Free Cash Flow Growth | 1,690.10% | 105.16% | -315.05% | 2,420.71% |
| Safety | ||||
| Net Debt / EBITDA | -0.61 | 0.09 | 1.94 | -2.30 |
| Interest Coverage | 1.46 | 5.27 | -0.40 | 7.50 |
| Efficiency | ||||
| Inventory Turnover | 0.58 | 0.65 | 0.68 | 0.71 |
| Cash Conversion Cycle | 631.00 | 572.42 | 553.83 | 521.96 |